nach oben

European Journal of Nutrition

Erschienen in:

15.04.2020 | Original Contribution

Flaxseed and/or hesperidin supplementation in metabolic syndrome: an open-labeled randomized controlled trial

verfasst von: Zahra Yari, Makan Cheraghpour, Azita Hekmatdoost

Erschienen in: European Journal of Nutrition | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of the present study was to compare the clinical effect of flaxseed and hesperidin alone and with combination in patients with metabolic syndrome. Number of participants with treated metabolic syndrome was assessed as a primary end point.

Methods

In this 12-week randomized controlled trial, ninety-eight patients with metabolic syndrome randomly assigned to receive either whole flaxseed powder (30 g/day), or hesperidin (1 g/day), or combination of 30 g flaxseed and 1 g hesperidin or no supplement while adhering a lifestyle modification program.

Results

In comparison to control group, systolic blood pressure (− 5.68 vs. − 2.91 mmHg, P = 0.041) and serum concentrations of triglyceride (− 50.06 vs. 3.87 mg/dL, P = 0.033) in hesperidin group showed a significant reduction over 12 weeks of intervention. Comparison of the results of flaxseed group with the control group showed a significant improvement in serum concentrations of triglyceride (− 66 vs. 3.87 mg/dL, P = 0.028), insulin (− 4.27 vs. − 2.51 mU/L, P = 0.003) and accordingly insulin resistance (− 1.19 vs. − 0.76, P = 0.005) and sensitivity (0.03 vs. 0.01, P = 0.022) indices in flaxseed group. Combination of flaxseed and hesperidin improved three of five metabolic syndrome components including serum concentrations of triglyceride, glucose and systolic blood pressure as compared to placebo. Interestingly, co-administration of flaxseed and hesperidin with 77.3% reduction in the prevalence of defined metabolic syndrome was revealed to be most effective in controlling the metabolic syndrome, after which the group of flaxseed with 76% reduction and hesperidin group with 54.5% reduction were ranked second and third, respectively.

Conclusions

It can be concluded that co-administration of flaxseed and hesperidin appears to be superior to either supplementation alone on metabolic syndrome treatment, while the effects of flaxseed are stronger than hesperidin supplementation.

Nur mit Berechtigung zugänglich

Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112(17):2735–2752PubMed

Esmaillzadeh A, Mirmiran P, Azadbakht L, Etemadi A, Azizi F (2006) High prevalence of the metabolic syndrome in Iranian adolescents. Obesity 14(3):377–382PubMed

Azizi F, Salehi P, Etemadi A, Zahedi-Asl S (2003) Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract 61(1):29–37PubMed

Grundy SM, Cleeman JI, Merz CNB, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ (2004) Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. J Am Coll Cardiol 44(3):720–732PubMed

Power M, Pratley R (2011) Alternative and complementary treatments for metabolic syndrome. Curr DiabRep 11(3):173–178

Graf BL, Raskin I, Cefalu WT, Ribnicky DM (2010) Plant-derived therapeutics for the treatment of metabolic syndrome. Curr Opin Investig Drugs (London, England: 2000) 11(10):1107

Ehteshami M, Shakerhosseini R, Sedaghat F, Hedayati M, Eini-Zinab H, Hekmatdoost A (2018) The effect of gluten free diet on components of metabolic syndrome: a randomized clinical trial. Asian Pac J Cancer Prev APJCP 19(10):2979–2984. https://doi.org/10.22034/apjcp.2018.19.10.2979CrossRefPubMed

Hekmatdoost A, Mirmiran P, Hosseini-Esfahani F, Azizi F (2011) Dietary fatty acid composition and metabolic syndrome in Tehranian adults. Nutrition 27(10):1002–1007. https://doi.org/10.1016/j.nut.2010.11.004CrossRefPubMed

Reilly MP, Rader DJ (2003) The metabolic syndrome: more than the sum of its parts? Circulation 108(13):1546–1551PubMed

10.

Finicelli M, Squillaro T, Di Cristo F, Di Salle A, Melone MAB, Galderisi U, Peluso G (2019) Metabolic syndrome, Mediterranean diet, and polyphenols: Evidence and perspectives. J Cell Physiol 234(5):5807–5826. https://doi.org/10.1002/jcp.27506CrossRefPubMed

11.

Sohrab G, Ebrahimof S, Hosseinpour-Niazi S, Yuzbashian E, Mirmiran P, Azizi F (2018) Association of dietary intakes of total polyphenol and its subclasses with the risk of metabolic syndrome: tehran lipid and glucose study. Metab Syndr Relat Disord 16(6):274–281. https://doi.org/10.1089/met.2017.0140CrossRefPubMed

12.

Selvamuthukumaran M, Boobalan MS, Shi J (2017) Bioactive components in citrus fruits and their health benefits. In: Phytochemicals in citrus: applications in functional foods

13.

Assini JM, Mulvihill EE, Huff MW (2013) Citrus flavonoids and lipid metabolism. Curr Opin Lipidol 24(1):34–40. https://doi.org/10.1097/MOL.0b013e32835c07fdCrossRefPubMed

14.

Sekgala MD, McHiza ZJ, Parker WA, Monyeki KD (2018) Dietary fiber intake and metabolic syndrome risk factors among young South African Adults. Nutrients. https://doi.org/10.3390/nu10040504CrossRefPubMedPubMedCentral

15.

Chen JP, Chen GC, Wang XP, Qin L, Bai Y (2017) Dietary fiber and metabolic syndrome: a meta-analysis and review of related mechanisms. Nutrients. https://doi.org/10.3390/nu10010024CrossRefPubMedPubMedCentral

16.

Poudyal H, Panchal SK, Diwan V, Brown L (2011) Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action. Prog Lipid Res 50(4):372–387. https://doi.org/10.1016/j.plipres.2011.06.003CrossRefPubMed

17.

Ganorkar P, Jain R (2013) Flaxseed–a nutritional punch. Int Food Res J 20(2):519–525

18.

Morris DH (2007) Flax: A health and nutrition primer. Flax Council of Canada

19.

Hall C, Tulbek MC, Xu Y (2006) Flaxseed. Adv Food Nutr Res 51:1–97PubMed

20.

Homayouni F, Haidari F, Hedayati M, Zakerkish M, Ahmadi K (2017) Hesperidin supplementation alleviates oxidative DNA damage and lipid peroxidation in type 2 diabetes: a randomized double-blind placebo-controlled clinical trial. Phytother Res PTR 31(10):1539–1545. https://doi.org/10.1002/ptr.5881CrossRefPubMed

21.

Hutchins AM, Brown BD, Cunnane SC, Domitrovich SG, Adams ER, Bobowiec CE (2013) Daily flaxseed consumption improves glycemic control in obese men and women with pre-diabetes: a randomized study. Nutr Res (New York, NY) 33(5):367–375. https://doi.org/10.1016/j.nutres.2013.02.012CrossRef

22.

Constans J, Bennetau-Pelissero C, Martin JF, Rock E, Mazur A, Bedel A, Morand C, Berard AM (2015) Marked antioxidant effect of orange juice intake and its phytomicronutrients in a preliminary randomized cross-over trial on mild hypercholesterolemic men. Clin Nutr (Edinburgh, Scotland) 34(6):1093–1100. https://doi.org/10.1016/j.clnu.2014.12.016CrossRef

23.

Lucas EA, Wild RD, Hammond LJ, Khalil DA, Juma S, Daggy BP, Stoecker BJ, Arjmandi BH (2002) Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women. J Clin Endocrinol Metab 87(4):1527–1532. https://doi.org/10.1210/jcem.87.4.8374CrossRefPubMed

24.

Homayouni F, Haidari F, Hedayati M, Zakerkish M, Ahmadi K (2018) Blood pressure lowering and anti-inflammatory effects of hesperidin in type 2 diabetes; a randomized double-blind controlled clinical trial. Phytother Res PTR 32(6):1073–1079. https://doi.org/10.1002/ptr.6046CrossRefPubMed

25.

Machado AM, de Paula H, Cardoso LD, Costa NM (2015) Effects of brown and golden flaxseed on the lipid profile, glycemia, inflammatory biomarkers, blood pressure and body composition in overweight adolescents. Nutrition (Burbank, Los Angeles County, Calif) 31(1):90–96. https://doi.org/10.1016/j.nut.2014.05.002CrossRef

26.

Kim JY, Jung KJ, Choi JS, Chung HY (2006) Modulation of the age-related nuclear factor-κB (NF-κB) pathway by hesperetin. Aging Cell 5(5):401–411PubMed

27.

Expert Panel on Detection E (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285(19):2486

28.

Yari Z, Rahimlou M, Poustchi H, Hekmatdoost A (2016) Flaxseed supplementation in metabolic syndrome management: a pilot randomized, open-labeled, controlled study. Phytother Res 30(8):1339–1344PubMed

29.

Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum RJ, Erdman JW Jr, Kris-Etherton P, Goldberg IJ, Kotchen TA (2000) AHA Dietary Guidelines: revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 102(18):2284–2299PubMed

30.

Kelishadi R, Rabiei K, Khosravi A, Famouri F, Sadeghi M, Rouhafza H, Shirani S (2001) Assessment of physical activity of adolescents in Isfahan. J Shahrekord Univ Med Sci 3(2):55–66

31.

Pritchett AM, Foreyt JP, Mann DL (2005) Treatment of the metabolic syndrome: the impact of lifestyle modification. Cur Atheroscler Rep 7(2):95–102

32.

Wu H, Pan A, Yu Z, Qi Q, Lu L, Zhang G, Yu D, Zong G, Zhou Y, Chen X (2010) Lifestyle counseling and supplementation with flaxseed or walnuts influence the management of metabolic syndrome–4. J Nutr 140(11):1937–1942PubMedPubMedCentral

33.

Mulvihill EE, Huff WM (2012) Citrus flavonoids and the prevention of atherosclerosis. Cardiovasc Haematol Disord Drug Targets Form Curr Drug Targets Cardiovasc Hematol Disord 12(2):84–91

34.

Miwa Y, Mitsuzumi H, Sunayama T, Yamada M, Okada K, Kubota M, Chaen H, Mishima Y, Kibata M (2005) Glucosyl hesperidin lowers serum triglyceride level in hypertriglyceridemic subjects through the improvement of very low-density lipoprotein metabolic abnormality. J Nutr Sci Vitaminol 51(6):460–470PubMed

35.

Kurowska EM, Spence JD, Jordan J, Wetmore S, Freeman DJ, Piché LA, Serratore P (2000) HDL-cholesterol-raising effect of orange juice in subjects with hypercholesterolemia. Am J Clin Nutr 72(5):1095–1100PubMed

36.

Demonty I, Lin Y, Zebregs YE, Vermeer MA, van der Knaap HC, Jäkel M, Trautwein EA (2010) The citrus flavonoids hesperidin and naringin do not affect serum cholesterol in moderately hypercholesterolemic men and women–3. J Nutr 140(9):1615–1620PubMed

37.

Duval C, Müller M, Kersten S (2007) PPARα and dyslipidemia. Biochim Biophys Acta (BBA)-Mol Cell Biol Lipids 1771(8):961–971

38.

Torkan M, Entezari MH, Siavash M (2015) Effect of flaxseed on blood lipid level in hyperlipidemic patients. Rev Recent Clin Trials 10(1):61–67PubMed

39.

Akrami A, Nikaein F, Babajafari S, Faghih S, Yarmohammadi H (2018) Comparison of the effects of flaxseed oil and sunflower seed oil consumption on serum glucose, lipid profile, blood pressure, and lipid peroxidation in patients with metabolic syndrome. J Clinical Lipidol 12(1):70–77. https://doi.org/10.1016/j.jacl.2017.11.004CrossRef

40.

Zhang W, Wang X, Liu Y, Tian H, Flickinger B, Empie MW, Sun SZ (2008) Dietary flaxseed lignan extract lowers plasma cholesterol and glucose concentrations in hypercholesterolaemic subjects. Br J Nutr 99(6):1301–1309. https://doi.org/10.1017/s0007114507871649CrossRefPubMed

41.

Tai CC, Ding ST (2010) N-3 polyunsaturated fatty acids regulate lipid metabolism through several inflammation mediators: mechanisms and implications for obesity prevention. J Nutr Biochem 21(5):357–363PubMed

42.

Murase T, Aoki M, Tokimitsu I (2005) Supplementation with α-linolenic acid-rich diacylglycerol suppresses fatty liver formation accompanied by an up-regulation of β-oxidation in Zucker fatty rats. Biochim Biophys Acta (BBA)-Mol Cell Biol Lipids 1733(2):224–231

43.

Tapia G, Valenzuela R, Espinosa A, Romanque P, Dossi C, Gonzalez-Mañán D, Videla LA, D'espessailles A (2014) N-3 long-chain PUFA supplementation prevents high fat diet induced mouse liver steatosis and inflammation in relation to PPAR-α upregulation and NF-κB DNA binding abrogation. Mol Nutr Food Res 58(6):1333–1341PubMed

44.

Akiyama S, Katsumata S-i, Suzuki K, Ishimi Y, Wu J, Uehara M (2009) Dietary hesperidin exerts hypoglycemic and hypolipidemic effects in streptozotocin-induced marginal type 1 diabetic rats. J Clin Biochem Nutr 46(1):87–92PubMedPubMedCentral

45.

Akiyama S, Katsumata S-i, Suzuki K, Nakaya Y, Ishimi Y, Uehara M (2009) Hypoglycemic and hypolipidemic effects of hesperidin and cyclodextrin-clathrated hesperetin in Goto-Kakizaki rats with type 2 diabetes. Biosci Biotechnol Biochem 73(12):2779–2782PubMed

46.

Jung UJ, Lee M-K, Jeong K-S, Choi M-S (2004) The hypoglycemic effects of hesperidin and naringin are partly mediated by hepatic glucose-regulating enzymes in C57BL/KsJ-db/db mice. J Nutr 134(10):2499–2503PubMed

47.

Mahmoud AM, Ashour MB, Abdel-Moneim A, Ahmed OM (2012) Hesperidin and naringin attenuate hyperglycemia-mediated oxidative stress and proinflammatory cytokine production in high fat fed/streptozotocin-induced type 2 diabetic rats. J Diabetes Compl 26(6):483–490

48.

Rizza S, Muniyappa R, Iantorno M, Kim JA, Chen H, Pullikotil P, Senese N, Tesauro M, Lauro D, Cardillo C, Quon MJ (2011) Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome. J Clin Endocrinol Metab 96(5):E782–792. https://doi.org/10.1210/jc.2010-2879CrossRefPubMedPubMedCentral

49.

50.

Morisset A-S, Lemieux S, Veilleux A, Bergeron J, Weisnagel SJ, Tchernof A (2009) Impact of a lignan-rich diet on adiposity and insulin sensitivity in post-menopausal women. Br J Nutr 102(2):195–200PubMed

51.

Au MM, Goff HD, Kisch JA, Coulson A, Wright AJ (2013) Effects of soy-soluble fiber and flaxseed gum on the glycemic and insulinemic responses to glucose solutions and dairy products in healthy adult males. J Am Coll Nutr 32(2):98–100PubMed

52.

Hallund J, Tetens I, Bügel S, Tholstrup T, Bruun JM (2008) The effect of a lignan complex isolated from flaxseed on inflammation markers in healthy postmenopausal women. Nutr Metab Cardiovasc Dis 18(7):497–502PubMed

53.

Pan A, Sun J, Chen Y, Ye X, Li H, Yu Z, Wang Y, Gu W, Zhang X, Chen X (2007) Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, cross-over trial. PLoS ONE 2(11):e1148PubMedPubMedCentral

54.

Taghizadeh M, Jamilian M, Mazloomi M, Sanami M, Asemi Z (2016) A randomized-controlled clinical trial investigating the effect of omega-3 fatty acids and vitamin E co-supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes. J Clin Lipidol 10(2):386–393PubMed

55.

García-López S, Arriaga REV, Medina ON, López CPR, Figueroa-Valverde L, Cervera EG, Skidmore OM, Rosas-Nexticapa M (2016) One month of omega-3 fatty acid supplementation improves lipid profiles, glucose levels and blood pressure in overweight schoolchildren with metabolic syndrome. J Pediatr Endocrinol Metab 29(10):1143–1150PubMed

56.

Barre DE, Mizier-Barre KA, Griscti O, Hafez K (2008) High dose flaxseed oil supplementation may affect fasting blood serum glucose management in human type 2 diabetics. J Oleo Sci 57(5):269–273PubMed

57.

Mohammadi-Sartang M, Sohrabi Z, Barati-Boldaji R, Raeisi-Dehkordi H, Mazloom Z (2018) Flaxseed supplementation on glucose control and insulin sensitivity: a systematic review and meta-analysis of 25 randomized, placebo-controlled trials. Nutr Rev 76(2):125–139. https://doi.org/10.1093/nutrit/nux052CrossRefPubMed

58.

Dodin S, Lemay A, Jacques H, Legare F, Forest J-C, Masse B (2005) The effects of flaxseed dietary supplement on lipid profile, bone mineral density, and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled clinical trial. J Clin Endocrinol Metab 90(3):1390–1397PubMed

59.

Yamamoto M, Suzuki A, Hase T (2008) Short-term effects of glucosyl hesperidin and hesperetin on blood pressure and vascular endothelial function in spontaneously hypertensive rats. J Nutr Sci Vitaminol 54(1):95–98PubMed

60.

Ikemura M, Sasaki Y, Giddings JC, Yamamoto J (2012) Preventive effects of hesperidin, glucosyl hesperidin and naringin on hypertension and cerebral thrombosis in stroke-prone spontaneously hypertensive rats. Phytother Res 26(9):1272–1277PubMed

61.

Yamamoto M, Jokura H, Hashizume K, Ominami H, Shibuya Y, Suzuki A, Hase T, Shimotoyodome A (2013) Hesperidin metabolite hesperetin-7-O-glucuronide, but not hesperetin-3′-O-glucuronide, exerts hypotensive, vasodilatory, and anti-inflammatory activities. Food Funct 4(9):1346–1351PubMed

62.

Morand C, Dubray C, Milenkovic D, Lioger D, Martin JF, Scalbert A, Mazur A (2010) Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers. Am J Clin Nutr 93(1):73–80PubMed

63.

Berry EM, Hirsch J (1986) Does dietary linolenic acid influence blood pressure? Am J Clin Nutr 44(3):336–340PubMed

64.

Mayneris-Perxachs J, Guerendiain M, Castellote AI, Estruch R, Covas MI, Fitó M, Salas-Salvadó J, Martínez-González MA, Aros F, Lamuela-Raventós RM (2014) Plasma fatty acid composition, estimated desaturase activities, and their relation with the metabolic syndrome in a population at high risk of cardiovascular disease. Clin Nutr 33(1):90–97PubMed

65.

Wilmsen PK, Spada DS, Salvador M (2005) Antioxidant activity of the flavonoid hesperidin in chemical and biological systems. J Agric Food Chem 53(12):4757–4761PubMed

66.

Kasote D (2013) Flaxseed phenolics as natural antioxidants. Int Food Res J 20(1):27

67.

Puchau B, Zulet MA, de Echávarri AG, Hermsdorff HHM, Martínez JA (2010) Dietary total antioxidant capacity is negatively associated with some metabolic syndrome features in healthy young adults. Nutrition (Burbank, Los Angeles County, Calif) 26(5):534–541

68.

Li C, Schluesener H (2017) Health-promoting effects of the citrus flavanone hesperidin. Crit Rev Food Sci Nutr 57(3):613–631. https://doi.org/10.1080/10408398.2014.906382CrossRefPubMed

Titel: Flaxseed and/or hesperidin supplementation in metabolic syndrome: an open-labeled randomized controlled trial
verfasst von: Zahra Yari
Makan Cheraghpour
Azita Hekmatdoost
Publikationsdatum: 15.04.2020
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nutrition / Ausgabe 1/2021
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI: https://doi.org/10.1007/s00394-020-02246-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Flaxseed and/or hesperidin supplementation in metabolic syndrome: an open-labeled randomized controlled trial

Abstract

Purpose

Methods

Results

Conclusions

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2021

The association between antioxidant intake, dietary pattern and depressive symptoms in older Australian men: the Concord Health and Ageing in Men Project

Vitamin D and COVID-19 infection and mortality in UK Biobank

Protective effects of bovine milk exosomes against oxidative stress in IEC-6 cells

How do short-term associations between diet quality and metabolic risk vary with age?

Correction to: Adherence to a food group-based dietary guideline and incidence of prediabetes and type 2 diabetes

Dietary iodine, seaweed consumption, and incidence risk of metabolic syndrome among postmenopausal women: a prospective analysis of the Korean Multi-Rural Communities Cohort Study (MRCohort)

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

Update Innere Medizin